Original Article
Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy
Journal of Gastrointestinal Oncology
2025;
16
(1)
:1-16
.
(28 February 2025)
Hyperthermic intraperitoneal chemotherapy plus SOX chemotherapy versus SOX chemotherapy alone in patients with gastric cancer and peritoneal metastasis: a phase II randomized clinical trial
Journal of Gastrointestinal Oncology
2025;
16
(1)
:17-26
.
(28 February 2025)
The role of TMSB15A in gastric cancer progression and its prognostic significance
Journal of Gastrointestinal Oncology
2025;
16
(1)
:27-40
.
(28 February 2025)
The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study
Journal of Gastrointestinal Oncology
2025;
16
(1)
:41-52
.
(28 February 2025)
Predictive models of lymph node metastasis in patients with gastrointestinal stromal tumors based on machine learning algorithms: a SEER-based retrospective study
Journal of Gastrointestinal Oncology
2025;
16
(1)
:53-66
.
(28 February 2025)
Expression of Claudin18.2 in metastatic lesions in peritoneum of gastric cancer
Journal of Gastrointestinal Oncology
2025;
16
(1)
:67-76
.
(28 February 2025)
Development of a prognostic risk model for colorectal cancer and association of the prognostic model with cancer stem cell and immune cell infiltration
Journal of Gastrointestinal Oncology
2025;
16
(1)
:77-91
.
(28 February 2025)
Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases
Journal of Gastrointestinal Oncology
2025;
16
(1)
:92-105
.
(28 February 2025)
“Budding”—an early MRI feature established in a case-control study of perianal fistula mucinous adenocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(1)
:106-114
.
(28 February 2025)
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage
Journal of Gastrointestinal Oncology
2025;
16
(1)
:115-127
.
(28 February 2025)
Identification of a pyroptosis-related gene prognostic signature in patients with hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(1)
:128-145
.
(28 February 2025)
Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the in vivo prediction of individual hepatic clearance
Journal of Gastrointestinal Oncology
2025;
16
(1)
:146-158
.
(28 February 2025)
Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features
Journal of Gastrointestinal Oncology
2025;
16
(1)
:159-175
.
(28 February 2025)
Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2025;
16
(1)
:176-190
.
(28 February 2025)
PRMT5 attenuates regorafenib-induced DNA damage in hepatocellular carcinoma cells through symmetric dimethylation of RPL14
Journal of Gastrointestinal Oncology
2025;
16
(1)
:191-208
.
(28 February 2025)
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
Journal of Gastrointestinal Oncology
2025;
16
(1)
:209-225
.
(28 February 2025)
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2025;
16
(1)
:226-233
.
(28 February 2025)
A novel nebulized drug delivery system based on an innovative high-pressure peristaltic pump availably applied to pressurized intraperitoneal aerosol chemotherapy
Journal of Gastrointestinal Oncology
2025;
16
(1)
:234-248
.
(28 February 2025)
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes
Journal of Gastrointestinal Oncology
2025;
16
(1)
:249-263
.
(28 February 2025)
Construction and validation of a nomogram model for predicting peritoneal metastasis in gastric cancer based on ferroptosis-relate genes and clinicopathological features
Journal of Gastrointestinal Oncology
2025;
16
(1)
:264-280
.
(28 February 2025)
Review Article
A current knowledge of the undifferentiated carcinoma of the pancreas with osteoclast-like giant cells: a narrative review
Journal of Gastrointestinal Oncology
2025;
16
(1)
:281-291
.
(28 February 2025)
Case Report
Response to anti-EGFR therapy in chemo-refractory right-sided RAS wild-type metastatic colorectal cancer: a case report and literature review
Journal of Gastrointestinal Oncology
2025;
16
(1)
:292-300
.
(28 February 2025)
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therapy: a case report
Journal of Gastrointestinal Oncology
2025;
16
(1)
:301-308
.
(28 February 2025)
Systemic treatment for recurrence of hepatocellular carcinoma after liver transplantation: a case report
Journal of Gastrointestinal Oncology
2025;
16
(1)
:309-316
.
(28 February 2025)
Surgical Technique
The combination of extra-Glissonian pedicle ligation of the tumor-bearing area and traditional ALPPS: a novel modified ALPPS method
Journal of Gastrointestinal Oncology
2025;
16
(1)
:317-326
.
(28 February 2025)
Editorial
Insights on colorectal cancer mortality trends between 1999–2022 in the US: the importance of place and sex
Journal of Gastrointestinal Oncology
2025;
16
(1)
:327-329
.
(28 February 2025)
What is the significance of mismatch repair deficiency in stage IV colon cancer?
Journal of Gastrointestinal Oncology
2025;
16
(1)
:330-332
.
(28 February 2025)
Erratum
Erratum: MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway
Journal of Gastrointestinal Oncology
2025;
16
(1)
:333-335
.
(28 February 2025)
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study
Journal of Gastrointestinal Oncology
2025;
16
(1)
:336-341
.
(28 February 2025)
